COMMUNIQUÉS West-GlobeNewswire

The Alliance for Regenerative Medicine Launches Foundation to Promote Understanding and Acceptance of Potentially Curative Cell and Gene Therapies
06/06/2018
Non-profit will educate, engage, and empower patients, caregivers, scientists, and industry leaders WASHINGTON, DC, June 06, 2018 (GLOBE NEWSWIRE) -- As part of its ongoing efforts to accelerate patient access to safe, [...]
BioCorRx Raises $1.1 Million at Premium to Market
06/06/2018
ANAHEIM, CA, June 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced the Company [...]
AxoGen, Inc. to Present at Upcoming Investor Conferences
06/06/2018
William Blair 38 th Annual Growth Stock Conference, June 14 JMP Securities Life Sciences Conference, June 20 ALACHUA, Fla., June 06, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]
InMode Aesthetic Solutions Launches A New Concept for Subdermal Adipose-Remodeling of the Face, EmbraceRF and Morpheus8
06/06/2018
LAKE FOREST, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- InMode Aesthetic Solutions, the leader in cutting edge aesthetic medicine and technology solutions introduces EmbraceRF, a new facial contouring technique that [...]
Nightstar Therapeutics Reports First Quarter 2018 Financial Results and Acceleration of Preliminary NSR-RPGR Readout to Third Quarter 2018
06/06/2018
Preliminary data from dose escalation study in the Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigmentosa expected ahead of schedule in Q3 2018 Dose expansion study in the XIRIUS trial expected to begin enrollment in [...]
RavenQuest Announces Letter of Intent to Purchase Western Agripharma Ltd.
06/06/2018
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (the “ Company ” or “ RavenQuest ”) is pleased to announce that it has entered into a binding letter of intent with Western [...]
Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June
06/06/2018
SOUTH SAN FRANCISCO, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, announced today [...]
Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria
06/06/2018
Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif., June 06, 2018 (GLOBE [...]
ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.
06/06/2018
AGAATA delivers clinical reports in the fields of Reproductive Health, Oncology and Inherited Diseases. Amsterdam, The Netherlands -6 th June 2018 AGAATA innovates a fully integrated and certified CE-IVD Diagnostic [...]
Shire plc : Rule 2.9 announcement
06/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 6 June 2018 Shire [...]
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition
06/06/2018
Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s 2018 pipeline expansion Fraser Wright, Co-Founder and former Chief Technology Officer of Spark Therapeutics, [...]
NICOX : accord de collaboration de recherche avec Ironwood Pharmaceuticals pour de nouvelles thérapeutiques ophtalmiques
06/06/2018
Communiqué de presse Nicox : accord de collaboration de recherche avec Ironwood Pharmaceuticals pour de nouvelles thérapeutiques ophtalmiques ............................................. 6 juin 2018 - diffusion à 7h30 [...]
Nicox Announces Research Collaboration on Novel Ophthalmic Therapeutics with Ironwood Pharmaceuticals
06/06/2018
Press Release Nicox Announces Research Collaboration on Novel Ophthalmic Therapeutics with Ironwood Pharmaceuticals ................................................ June 6, 2018 - release at 7:30 am CET Sophia Antipolis [...]
Monthly information related to total number of voting rights and shares composing the share capital –May 31, 2018
06/06/2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers ERN France, June 06, 2018 (GLOBE NEWSWIRE) -- Monthly information related to total number of voting rights and shares composing the share [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social –31 mai 2018
06/06/2018
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers ERN France, 06 juin 2018 (GLOBE NEWSWIRE) -- Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital [...]
Sensorion Announces Oral Presentation at the 15th International Conference on Cochlear Implants and Other Implantable Auditory Technologies (Ci2018)
06/06/2018
The company will present preclinical data on the otoprotective capacity of SENS-401 which may benefit cochlear implant patients MONTPELLIER, France, June 06, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a [...]
Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period
06/06/2018
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second [...]
Takeda et TiGenix annoncent les résultats de la première période d'acceptation pour l'offre publique d'acquisition volontaire et conditionnelle de TiGenix et le début de la deuxième période d'accep...
06/06/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES Takeda et TiGenix annoncent les résultats de la première période d'acceptation pour l'offre publique d'acquisition volontaire et conditionnelle de [...]
MDxHealth launch agreement with Philips for prognostic prostate cancer biomarker
06/06/2018
NEWS RELEASE MDxHealth announces worldwide licencing agreement with Philips for prognostic prostate cancer biomarker Agreement with Philips facilitates the launch of InformMDx(TM) HERSTAL, BELGIUM and IRVINE, CA - 07:00 [...]

Pages